Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20036092HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20017351HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20048165HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20032195HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20048227HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20014117HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20046071HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20035969HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20047199HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS20047468HPVENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TCGA Plot Options
Drug Information
GeneDPYD
DrugBank IDDB03516
Drug NameEniluracil
Target IDBE0000960
UniProt IDQ12882
Regulation Type
PubMed IDs16466986
CitationsCzito BG, Hong TJ, Cohen DP, Petros WP, Tyler DS, Pappas TN, Yu D, Lee CG, Lockhart AC, Morse MA, Fernando N, Hurwitz HI: A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. Cancer Invest. 2006 Feb;24(1):9-17.
GroupsInvestigational
Direct ClassificationPyrimidones
SMILESO=C1NC=C(C#C)C(=O)N1
Pathways
PharmGKB
ChEMBLCHEMBL355200